Patrick Serruys Spencer King PATRICK SERRUYS, Erasmus University, Rotterdam COMMENT: SPENCER KING, Piedmont Hospital, Atlanta REFERENCE: Abstract 2402-3, American College of Cardiology New Orleans Six
Patrick Serruys
Spencer King
PATRICK SERRUYS, Erasmus University, RotterdamCOMMENT: SPENCER KING, Piedmont Hospital, Atlanta
REFERENCE: Abstract 2402-3, American College of Cardiology New OrleansSix-months follow-up of patients receiving a new bioabsorbable drug-eluting stent are favourable, according toPatrick Serruyswhose group has been investigating the stent which elutes everolimus in a group of 30 patients. During the ACC Annual Meeting in New Orleans he discussed with Peter Goodwin the potential benefits the new device can bring to coronary patients.
Related Episodes
Audio Journal of Oncology Volume 16 Number 11
Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan) Sarah Maxwell and Peter Goodwin report from: American Society of Clinical Oncology
Remove Thrombus Before Primary Angioplasty!
Felix Zijlstra Felix Zijlstra, University Medical Center Groningen, The Netherlands Thrombus aspiration before percutaneous coronary intervention for acute myocardial infarction has multiple benefits,
